RECENT FEATURE ARTICLES
Effective cleaning and disinfection protocols are vital to minimise the risk of cross-infection in hospitals. Kayleigh Cox-Nowak provides an insight into effective protocols to reduce the risk of transmission of healthcare-associated infections.
Tony Cambridge provides a brief overview of the development of POCT and his evolving role in this near-patient service, and introduces a new website, including interactive media, devoted to all aspects of rapid and decentralised diagnostics.
Following publication of a report compiled by Roche Diagnostics, three leading experts who contributed to the document discuss the impact that the SARS-CoV-2 pandemic has had on the industry, the challenges ahead, and their visions for the future.
Christopher Reilly-Stitt reports on two UK NEQAS BC webinars held in April and July, and the response received from an international online audience.
The development of new nucleic acid amplification techniques is bringing molecular diagnostics closer to the patient for faster results and improved patient management. A prime example of this latest near-patient capability is LAMP technology.
The SARS-CoV-2 pandemic has brought many challenges that have driven the need to manage patients differently. Amanda Appleton and Emma Isom explain how the increased use of novel diagnostic solutions has helped to address issues in gastroenterology.
For over 50 years Sysmex has innovated and revolutionised the fields of haematology, haemostasis and urinalysis. Here, the company revisits some of the key landmarks in the history of Sysmex and how they have helped shape today's laboratories.
A brief preview of the upcoming Biomedical Science Congress event focusing on some of the speakers on the scientific programme.
Victoria Tuckley summarises the 2020 Annual Report. Here, she also highlights how lessons can be learned about communication and robust planning for future emergency situations where the environment is continuously evolving.
This month’s cover story looks at vaccine-induced thrombocytopenia and thrombosis (VITT), a rare side-effect of the ChAdOx1 nCoV-19 adenoviral vector vaccine. The following examples of open-access current research expand on this theme.
Testing is fundamental to identify and prevent the spread of SARS-CoV-2, but how can laboratories access automation technologies to respond to increased demand? Penny Pinnock explores how smart finance can help laboratories enhance testing capacity.
Vaccine-induced immune thrombocytopenia and thrombosis has been identified as a rare side effect of the ChAdOx1 nCoV-19 adenoviral vector vaccine. Alex Stephenson-Brown explains how an ELISA from Stago can detect cases of the condition.
Laboratories across the world use cytocentrifugation to present cells for microscopic analysis while maintaining their morphology. Here, Epredia gives a brief history of the Cytospin and the use of cytology samples to detect respiratory viruses.
South Korea’s response to the pandemic has been widely praised, achieving success through rigorous preparation, rapid response for detection and appropriate containment and treatment, with almost immediate access to PCR tests.
As the health service responds to the various backlogs that have developed as a result of the ongoing pandemic, Chris Hudson provides a brief overview of Roche digital solutions and how they facilitate better patient care.
In the background of COVID-19, there is another silent pandemic growing – the threat of antimicrobial resistance. In vitro diagnostics are vital in the fight against AMR, ensuring appropriate administration of antibiotics and reducing their misuse.
In March 2022, the delayed fourteenth iteration in the biennial Congress series will return to the ICC in Birmingham. The focus will be on the very best that biomedical science and commercial colleagues have to offer.
Now embarking on the final article in his series on method comparisons. Stephen MacDonald concludes with advice on preparation of the documentation and final report.
The detection of SARS-CoV-2 mutations and new, potentially more infectious and transmissible variants of the virus currently is exercising the minds of the scientific and commercial communities. PerkinElmer examines the various testing methodologies.